{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:19:27Z","timestamp":1772637567819,"version":"3.50.1"},"reference-count":73,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["19-75-10030"],"award-info":[{"award-number":["19-75-10030"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>The biosafety of gene therapy remains a crucial issue for both the direct and cell-mediated delivery of recombinant cDNA encoding biologically active molecules for the pathogenetic correction of congenital or acquired disorders. The diversity of vector systems and cell carriers for the delivery of therapeutic genes revealed the difficulty of developing and implementing a safe and effective drug containing artificial genetic material for the treatment of human diseases in practical medicine. Therefore, in this study we assessed changes in the transcriptome and secretome of umbilical cord blood mononuclear cells (UCB-MCs) genetically modified using adenoviral vector (Ad5) carrying cDNA encoding human vascular endothelial growth factor (VEGF165) or reporter green fluorescent protein (GFP). A preliminary analysis of UCB-MCs transduced with Ad5-VEGF165 and Ad5-GFP with MOI of 10 showed efficient transgene expression in gene-modified UCB-MCs at mRNA and protein levels. The whole transcriptome sequencing of native UCB-MCs, UCB-MC+Ad5-VEGF165, and UCB-MC+Ad5-GFP demonstrated individual sample variability rather than the effect of Ad5 or the expression of recombinant vegf165 on UCB-MC transcriptomes. A multiplex secretome analysis indicated that neither the transduction of UCB-MCs with Ad5-GFP nor with Ad5-VEGF165 affects the secretion of the studied cytokines, chemokines, and growth factors by gene-modified cells. Here, we show that UCB-MCs transduced with Ad5 carrying cDNA encoding human VEGF165 efficiently express transgenes and preserve transcriptome and secretome patterns. This data demonstrates the biosafety of using UCB-MCs as cell carriers of therapeutic genes.<\/jats:p>","DOI":"10.3390\/biomedicines11072020","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:54:01Z","timestamp":1689728041000},"page":"2020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA In Vitro"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6988-0673","authenticated-orcid":false,"given":"Ilnur I.","family":"Salafutdinov","sequence":"first","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan 420012, Russia"},{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-8314","authenticated-orcid":false,"given":"Dilara Z.","family":"Gatina","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7445-2091","authenticated-orcid":false,"given":"Maria I.","family":"Markelova","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina E.","family":"Garanina","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey Yu.","family":"Malanin","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilnaz M.","family":"Gazizov","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan 420012, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8128-4636","authenticated-orcid":false,"given":"Andrei A.","family":"Izmailov","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan 420012, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9427-5739","authenticated-orcid":false,"given":"Albert A.","family":"Rizvanov","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6632-4636","authenticated-orcid":false,"given":"Rustem R.","family":"Islamov","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan 420012, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e1s","family":"Palot\u00e1s","sequence":"additional","affiliation":[{"name":"Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan 420008, Russia"},{"name":"Asklepios-Med (Private Medical Practice and Research Center), H-6722 Szeged, Hungary"},{"name":"Tokaj-Hegyalja University, H-3910 Tokaj, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zufar Z.","family":"Safiullov","sequence":"additional","affiliation":[{"name":"Department of Histology, Cytology and Embryology, Kazan State Medical University, Kazan 420012, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15252\/emmm.201707573","article-title":"Gene Therapy for ADA-SCID, the First Marketing Approval of an Ex Vivo Gene Therapy in Europe: Paving the Road for the next Generation of Advanced Therapy Medicinal Products","volume":"9","author":"Aiuti","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ymthe.2020.12.007","article-title":"Current Clinical Applications of In Vivo Gene Therapy with AAVs","volume":"29","author":"Mendell","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s13311-018-00694-0","article-title":"Gene Therapy for Neurodegenerative Diseases","volume":"16","author":"Sudhakar","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex Vivo Gene Transfer and Correction for Cell-Based Therapies","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/5584_2019_463","article-title":"The Horizon of Gene Therapy in Modern Medicine: Advances and Challenges","volume":"1247","author":"Arjmand","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1038\/sj.gt.3302629","article-title":"Gene Therapy Bio-Safety: Scientific and Regulatory Issues","volume":"12","author":"Gonin","year":"2005","journal-title":"Gene Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jclinpath-2019-205952","article-title":"Molecular Pathology of Neurodegenerative Diseases: Principles and Practice","volume":"72","author":"Kovacs","year":"2019","journal-title":"J. Clin. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/neuros\/nyw080","article-title":"Traumatic Spinal Cord Injury\u2014Repair and Regeneration","volume":"80","author":"Ahuja","year":"2017","journal-title":"Neurosurgery"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.amjmed.2021.07.027","article-title":"Ischemic Stroke","volume":"134","author":"Feske","year":"2021","journal-title":"Am. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MCC.0000000000001005","article-title":"Neurotrauma","volume":"28","author":"Niziolek","year":"2022","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1126\/science.270.5235.475","article-title":"T Lymphocyte-Directed Gene Therapy for ADA-SCID: Initial Trial Results after 4 Years","volume":"270","author":"Blaese","year":"1995","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","article-title":"Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy","volume":"326","author":"Cartier","year":"2009","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","article-title":"Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned","volume":"21","author":"Morgan","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-3-030-31206-0_3","article-title":"Hematopoietic Stem and Progenitor Cells (HSPCs)","volume":"1201","author":"Bujko","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/bs.ctdb.2016.01.009","article-title":"Hematopoietic Stem Cell and Its Bone Marrow Niche","volume":"118","author":"Yu","year":"2016","journal-title":"Curr. Top. Dev. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102952","DOI":"10.1016\/j.transci.2020.102952","article-title":"Umbilical Cord Blood: Current Uses for Transfusion and Regenerative Medicine","volume":"59","author":"Orlando","year":"2020","journal-title":"Transfus. Apher. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/MOH.0000000000000732","article-title":"Umbilical Cord Blood: An Undervalued and Underutilized Resource in Allogeneic Hematopoietic Stem Cell Transplant and Novel Cell Therapy Applications","volume":"29","author":"Shi","year":"2022","journal-title":"Curr. Opin. Hematol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.pediatrneurol.2012.10.010","article-title":"Pluripotent Possibilities: Human Umbilical Cord Blood Cell Treatment after Neonatal Brain Injury","volume":"48","author":"Verina","year":"2013","journal-title":"Pediatr. Neurol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.2000.01986.x","article-title":"Mesenchymal Progenitor Cells in Human Umbilical Cord Blood","volume":"109","author":"Erices","year":"2000","journal-title":"Br. J. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3727\/096368910X","article-title":"Mesenchymal Stem Cells","volume":"20","author":"Ding","year":"2011","journal-title":"Cell Transplant."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1479-5876-8-75","article-title":"Safety Evaluation of Allogeneic Umbilical Cord Blood Mononuclear Cell Therapy for Degenerative Conditions","volume":"8","author":"Yang","year":"2010","journal-title":"J. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11064-007-9426-6","article-title":"Umbilical Cord Blood Stem Cell Mediated Downregulation of Fas Improves Functional Recovery of Rats after Spinal Cord Injury","volume":"33","author":"Dasari","year":"2008","journal-title":"Neurochem. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jcyt.2015.03.004","article-title":"Cord Blood for Brain Injury","volume":"17","author":"Sun","year":"2015","journal-title":"Cytotherapy"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/BF03033155","article-title":"Human Umbilical Cord Blood (HUCB) Cells for Central Nervous System Repair","volume":"5","author":"Newman","year":"2003","journal-title":"Neurotox. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/stem.3150","article-title":"Using Umbilical Cord Blood for Regenerative Therapy: Proof or Promise?","volume":"38","author":"Allan","year":"2020","journal-title":"Stem Cells"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2174\/1567202043362261","article-title":"Use of Human Umbilical Cord Blood (HUCB) Cells to Repair the Damaged Brain","volume":"1","author":"Newman","year":"2004","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neulet.2005.01.070","article-title":"Human Umbilical Cord Blood Cells Express Neurotrophic Factors","volume":"380","author":"Fan","year":"2005","journal-title":"Neurosci. Lett."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000046537","article-title":"Hematologic and Immunophenotypic Characterization of Human Umbilical Cord Blood","volume":"105","author":"Pranke","year":"2001","journal-title":"Acta Haematol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bachstetter, A.D., Pabon, M.M., Cole, M.J., Hudson, C.E., Sanberg, P.R., Willing, A.E., Bickford, P.C., and Gemma, C. (2008). Peripheral Injection of Human Umbilical Cord Blood Stimulates Neurogenesis in the Aged Rat Brain. BMC Neurosci., 9.","DOI":"10.1186\/1471-2202-9-22"},{"key":"ref_30","first-page":"173","article-title":"Parkinson\u2019s Disease Mice and Human Umbilical Cord Blood","volume":"33","author":"Ende","year":"2002","journal-title":"J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Garbuzova-Davis, S., Sanberg, C.D., Kuzmin-Nichols, N., Willing, A.E., Gemma, C., Bickford, P.C., Miller, C., Rossi, R., and Sanberg, P.R. (2008). Human Umbilical Cord Blood Treatment in a Mouse Model of ALS: Optimization of Cell Dose. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0002494"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0024-3205(00)00602-0","article-title":"Human Umbilical Cord Blood Effect on Sod Mice (Amyotrophic Lateral Sclerosis)","volume":"67","author":"Ende","year":"2000","journal-title":"Life Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000331327","article-title":"Intraspinal Injection of Human Umbilical Cord Blood-Derived Cells Is Neuroprotective in a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis","volume":"9","author":"Knippenberg","year":"2012","journal-title":"Neurodegener. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.46582\/jsrm.1402011","article-title":"Intra-Arterial Transplantation of Human Umbilical Cord Blood Mononuclear Cells in Sub-Acute Ischemic Stroke Increases VEGF Expression in Rats","volume":"14","author":"Ramli","year":"2018","journal-title":"J. Stem Cells Regen. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous Administration of Human Umbilical Cord Blood Reduces Behavioral Deficits after Stroke in Rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/s13287-022-03153-y","article-title":"Human Umbilical Cord Blood Mononuclear Cells Transplantation for Perinatal Brain Injury","volume":"13","author":"Xi","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3727\/096368916X691411","article-title":"Phase I-II Clinical Trial Assessing Safety and Efficacy of Umbilical Cord Blood Mononuclear Cell Transplant Therapy of Chronic Complete Spinal Cord Injury","volume":"25","author":"Zhu","year":"2016","journal-title":"Cell Transplant."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2174\/1566523215666150126122317","article-title":"Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis after Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neur","volume":"15","author":"Islamov","year":"2015","journal-title":"Curr. Gene Ther."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neures.2008.06.008","article-title":"VEGF and ALS","volume":"62","author":"Sathasivam","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nrneurol.2016.88","article-title":"Vascular Endothelial Growth Factor: A Neurovascular Target in Neurological Diseases","volume":"12","author":"Lange","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The Biology of VEGF and Its Receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1152\/physrev.00031.2008","article-title":"Role and Therapeutic Potential of VEGF in the Nervous System","volume":"89","author":"Lambrechts","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1002\/jnr.23088","article-title":"Effects of Vascular Endothelial Growth Factor in Ischemic Stroke","volume":"90","author":"Ma","year":"2012","journal-title":"J. Neurosci. Res."},{"key":"ref_44","first-page":"127","article-title":"The Role of Vascular Endothelial Growth Factor in Ischemic Stroke","volume":"76","author":"Chen","year":"2021","journal-title":"Pharmazie"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2020.04.042","article-title":"VEGI Improves Outcomes in the Early Phase of Experimental Traumatic Brain Injury","volume":"438","author":"Zhou","year":"2020","journal-title":"Neuroscience"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/jcbfm.2009.271","article-title":"Vascular Endothelial Growth Factor Increases Neurogenesis after Traumatic Brain Injury","volume":"30","author":"Shohami","year":"2010","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1089\/neu.2012.2444","article-title":"Treatment of Traumatic Brain Injury Using Zinc-Finger Protein Gene Therapy Targeting VEGF-A","volume":"29","author":"Siddiq","year":"2012","journal-title":"J. Neurotrauma"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fncel.2017.00381","article-title":"Effect of VEGF on Inflammatory Regulation, Neural Survival, and Functional Improvement in Rats Following a Complete Spinal Cord Transection","volume":"11","author":"Li","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1097\/BRS.0000000000003333","article-title":"Vascular Endothelial Growth Factor-Transfected Bone Marrow Mesenchymal Stem Cells Improve the Recovery of Motor and Sensory Functions of Rats With Spinal Cord Injury","volume":"45","author":"Liu","year":"2020","journal-title":"Spine"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Pronto-Laborinho, A.C., Pinto, S., and de Carvalho, M. (2014). Roles of Vascular Endothelial Growth Factor in Amyotrophic Lateral Sclerosis. Biomed. Res. Int., 2014.","DOI":"10.1155\/2014\/947513"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ng1211","article-title":"VEGF Is a Modifier of Amyotrophic Lateral Sclerosis in Mice and Humans and Protects Motoneurons against Ischemic Death","volume":"34","author":"Lambrechts","year":"2003","journal-title":"Nat. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Agatieva, E., Ksembaev, S., Sokolov, M., Markosyan, V., Gazizov, I., Tsyplakov, D., Shmarov, M., Tutykhina, I., Naroditsky, B., and Logunov, D. (2021). Evaluation of Direct and Cell-Mediated Lactoferrin Gene Therapy for the Maxillofacial Area Abscesses in Rats. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010058"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Gatina, D.Z., Gazizov, I.M., Zhuravleva, M.N., Arkhipova, S.S., Golubenko, M.A., Gomzikova, M.O., Garanina, E.E., Islamov, R.R., Rizvanov, A.A., and Salafutdinov, I.I. (2023). Induction of Angiogenesis by Genetically Modified Human Umbilical Cord Blood Mononuclear Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054396"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainresbull.2017.05.005","article-title":"Evaluation of Direct and Cell-Mediated Triple-Gene Therapy in Spinal Cord Injury in Rats","volume":"132","author":"Islamov","year":"2017","journal-title":"Brain Res. Bull."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Markosyan, V., Safiullov, Z., Izmailov, A., Fadeev, F., Sokolov, M., Kuznetsov, M., Trofimov, D., Kim, E., Kundakchyan, G., and Gibadullin, A. (2020). Preventive Triple Gene Therapy Reduces the Negative Consequences of Ischemia-Induced Brain Injury after Modelling Stroke in a Rat. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21186858"},{"key":"ref_56","first-page":"e52065","article-title":"Viral Concentration Determination through Plaque Assays: Using Traditional and Novel Overlay Systems","volume":"4","author":"Baer","year":"2014","journal-title":"J. Vis. Exp."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/(SICI)1097-0320(19990801)36:4<333::AID-CYTO8>3.0.CO;2-F","article-title":"Analysis with Flow Cytometry of Green Fluorescent Protein Expression in Leukemic Cells","volume":"36","author":"Chu","year":"1999","journal-title":"Cytometry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/sc.2015.162","article-title":"Construction of Recombinant Adenovirus Containing Picorna-Viral 2A-Peptide Sequence for the Co-Expression of Neuro-Protective Growth Factors in Human Umbilical Cord Blood Cells","volume":"54","author":"Garanina","year":"2016","journal-title":"Spinal Cord"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0076-6879(86)18114-6","article-title":"ELISA Techniques","volume":"Volume 118","author":"Clark","year":"1986","journal-title":"Plant Molecular Biology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/7651_2014_94","article-title":"Multiplex Immunoassays for Quantification of Cytokines, Growth Factors, and Other Proteins in Stem Cell Communication","volume":"1212","author":"Valekova","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1101\/pdb.top084970","article-title":"RNA Sequencing and Analysis","volume":"2015","author":"Kukurba","year":"2015","journal-title":"Cold Spring Harb. Protoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-Optimal Probabilistic RNA-Seq Quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: Gene Set Analysis Toolkit with Revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.yapd.2019.04.001","article-title":"Gene Therapy: Current Applications and Future Possibilities","volume":"66","author":"Steffin","year":"2019","journal-title":"Adv. Pediatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/1535676020942195","article-title":"Biosafety Practices for In Vivo Viral-Mediated Gene Therapy in the Health Care Setting","volume":"25","author":"Blind","year":"2020","journal-title":"Appl. Biosaf."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","article-title":"Gene Therapy","volume":"381","author":"High","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/14712598.2017.1316713","article-title":"Advances in Umbilical Cord Blood Cell Therapy: The Present and the Future","volume":"17","author":"Berglund","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1291\/hypres.27.119","article-title":"Development of Angiogenic Cell and Gene Therapy by Transplantation of Umbilical Cord Blood with Vascular Endothelial Growth Factor Gene","volume":"27","author":"Ikeda","year":"2004","journal-title":"Hypertens. Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Das, H., George, J.C., Joseph, M., Das, M., Abdulhameed, N., Blitz, A., Khan, M., Sakthivel, R., Mao, H.-Q., and Hoit, B.D. (2009). Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007325"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1365-2362.2005.01565.x","article-title":"Combined Cord Blood Stem Cells and Gene Therapy Enhances Angiogenesis and Improves Cardiac Performance in Mouse after Acute Myocardial Infarction","volume":"35","author":"Chen","year":"2005","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1007\/s12035-016-0017-x","article-title":"Tandem Delivery of Multiple Therapeutic Genes Using Umbilical Cord Blood Cells Improves Symptomatic Outcomes in ALS","volume":"54","author":"Islamov","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Islamov, R., Bashirov, F., Fadeev, F., Shevchenko, R., Izmailov, A., Markosyan, V., Sokolov, M., Kuznetsov, M., Davleeva, M., and Garifulin, R. (2020). Epidural Stimulation Combined with Triple Gene Therapy for Spinal Cord Injury Treatment. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21238896"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:14:07Z","timestamp":1760127247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["biomedicines11072020"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11072020","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]}}}